Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study

被引：0
|
作者：
Ron, IG
Sarid, DL
Wigler, N
Inbar, MJ
机构：
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer - A phase II study
    Sarid, David
    Ron, Ilan G.
    Sperber, Fani
    Stadler, Yona
    Kahan, Perry
    Kovner, Felix
    Ben-Yosef, Rami
    Marmor, Sylvia
    Grinberg, Yulia
    Maimon, Natalie
    Weinstein, Juliana
    Yaal-Hahoshen, Neora
    CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 691 - 701
  • [2] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: A phase II study.
    Sarid, D
    Ron, I
    Inbar, M
    Barak, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 92S - 92S
  • [3] Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive Breast CancerA Phase II Study
    David Sarid
    Ilan G. Ron
    Fani Sperber
    Yona Stadler
    Perry Kahan
    Felix Kovner
    Rami Ben-Yosef
    Sylvia Marmor
    Yulia Grinberg
    Natalie Maimon
    Juliana Weinstein
    Neora Yaal-Hahoshen
    Clinical Drug Investigation, 2006, 26 : 691 - 701
  • [4] A PHASE II NEOADJUVANT TRIAL OF GENEXOL® (PACLITAXEL) AND EPIRUBICIN IN LOCALLY ADVANCED BREAST CANCER
    Kim, J.
    Lee, J.
    Ahn, B.
    Jeong, H.
    Byun, W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1060 - 1060
  • [5] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, D.
    Scalone, S.
    Crivellari, D.
    La Mura, N.
    Miolo, G.
    Murrone, A.
    Perin, T.
    Coran, F.
    Candiani, E.
    Massarut, S.
    Veronesi, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [6] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, Davide
    Scalone, Simona
    Crivellari, Diana
    Magri, Maria Donatella
    La Mura, Nicoletta
    Miolo, GianMaria
    Murrone, Antonio
    Perin, Tiziana
    Coran, Francesco
    Candiani, Ezio
    Massarut, Samuele
    Veronesi, Andrea
    TUMORI JOURNAL, 2010, 96 (02): : 229 - 233
  • [7] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
  • [8] A phase II trial of paclitaxel and epirubicin in advanced breast cancer
    Rischin, D.
    Smith, J.
    Millward, M.
    Lewis, C.
    Boyer, M.
    Richardson, G.
    Toner, G.
    Gurney, H.
    McKendrick, J.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 438 - 442
  • [9] A phase II trial of paclitaxel and epirubicin in advanced breast cancer
    D Rischin
    J Smith
    M Millward
    C Lewis
    M Boyer
    G Richardson
    G Toner
    H Gurney
    J McKendrick
    British Journal of Cancer, 2000, 83 : 438 - 442
  • [10] A phase II trial of epirubicin plus paclitaxel in metastatic breast cancer
    Carmichael, J
    Jones, A
    Hutchinson, T
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 44 - 47
12345